Mechanism of conjugated linoleic acid and vaccenic acid formation in human faecal suspensions and pure cultures of intestinal bacteria.
Faecal bacteria from four human donors and six species of human intestinal bacteria known to metabolize linoleic acid (LA) were incubated with LA in deuterium oxide-enriched medium to investigate the mechanisms of conjugated linoleic acid (CLA) and vaccenic acid (VA) formation. The main CLA products in faecal suspensions, rumenic acid (cis-9,trans-11-CLA; RA) and trans-9,trans-11-CLA, were labelled at C-13, as were other 9,11 geometric isomers. Traces of trans-10,cis-12-CLA formed were labelled to a much lower extent. In pure culture, Bifidobacterium breve NCFB 2258 formed labelled RA and trans-9,trans-11-CLA, while Butyrivibrio fibrisolvens 16.4, Roseburia hominis A2-183T, Roseburia inulinivorans A2-192T and Ruminococcus obeum-like strain A2-162 converted LA to VA, labelled in a manner indicating that VA was formed via C-13-labelled RA. Propionibacterium freudenreichii subsp. shermanii DSM 4902T, a possible probiotic, formed mainly RA with smaller amounts of trans-10,cis-12-CLA and trans-9,trans-11-CLA, labelled the same as in the mixed microbiota. Ricinoleic acid (12-OH-cis-9-18 : 1) did not form CLA in the mixed microbiota, in contrast to CLA formation described for Lactobacillus plantarum. These results were similar to those reported for the mixed microbiota of the rumen. Thus, although the bacterial genera and species responsible for biohydrogenation in the rumen and the human intestine differ, and a second route of RA formation via a 10-OH-18 : 1 is present in the intestine, the overall labelling patterns of different CLA isomers formation are common to both gut ecosystems. A hydrogen-abstraction enzymic mechanism is proposed that may explain the role of a 10-OH-18 : 1 intermediate in 9,11-CLA formation in pure and mixed cultures.
McIntosh
Freda M
FM
Gut Health Division, Rowett Research Institute, Bucksburn, Aberdeen AB21 9SB, UK.
Shingfield
Kevin J
KJ
MTT Agrifood Research Finland, FI-31600 Jokioinen, Finland.
Devillard
Estelle
E
Gut Health Division, Rowett Research Institute, Bucksburn, Aberdeen AB21 9SB, UK.
Russell
Wendy R
WR
Gut Health Division, Rowett Research Institute, Bucksburn, Aberdeen AB21 9SB, UK.
Wallace
R John
RJ
Gut Health Division, Rowett Research Institute, Bucksburn, Aberdeen AB21 9SB, UK.
D000328:Adult; D045856:Butyrivibrio / Q000254:growth & development* / Q000302:isolation & purification / Q000378:metabolism; D003470:Culture Media / Q000378:metabolism; D005243:Feces / Q000737:chemistry / Q000382:microbiology*; D006094:Gram-Positive Bacteria / Q000254:growth & development* / Q000302:isolation & purification / Q000378:metabolism; D006801:Humans; D007422:Intestines / Q000382:microbiology*; D007536:Isomerism; D044243:Linoleic Acids, Conjugated / Q000737:chemistry / Q000378:metabolism*; D008875:Middle Aged; D009829:Oleic Acids / Q000737:chemistry / Q000378:metabolism*
D003470:Culture Media; D044243:Linoleic Acids, Conjugated; D009829:Oleic Acids; C046938:9,11-linoleic acid; C050413:11-octadecenoic acid